JHS SVENDGAARD LABORATORIES
|
JHS SVENDGAARD LABORATORIES Last 5 Year Financial Ratios History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Operational & Financial Ratios | |||||
Earnings Per Share (Rs) | -2.38 | -0.62 | 0.19 | -0.32 | -0.11 |
CEPS(Rs) | -1.43 | 0.43 | 1.33 | 0.64 | 0.89 |
DPS(Rs) | - | - | - | - | - |
Book NAV/Share(Rs) | 26.55 | 28.60 | 27.56 | 29.16 | 28.97 |
Tax Rate(%) | 23.19 | 4,264.47 | -38.71 | 16.91 | 18.47 |
Margin Ratios | |||||
Core EBITDA Margin(%) | -11.54 | -0.98 | 1.90 | 1.19 | -0.47 |
EBIT Margin(%) | -21.62 | 1.74 | 2.19 | -2.78 | -0.81 |
Pre Tax Margin(%) | -22.70 | 0.12 | 0.96 | -4.17 | -1.65 |
PAT Margin (%) | -17.44 | -4.97 | 1.33 | -3.47 | -1.34 |
Cash Profit Margin (%) | -9.68 | 3.20 | 8.52 | 2.79 | 4.36 |
Performance Ratios | |||||
ROA(%) | -7.63 | -1.98 | 0.60 | -2.17 | -0.79 |
ROE(%) | -9.37 | -2.36 | 0.76 | -2.74 | -0.95 |
ROCE(%) | -11.59 | 0.82 | 1.24 | -2.15 | -0.56 |
Asset Turnover(x) | 0.44 | 0.40 | 0.45 | 0.63 | 0.59 |
Sales/Fixed Asset(x) | 0.98 | 0.96 | 1.16 | 1.59 | 1.42 |
Working Capital/Sales(x) | 1.85 | 1.44 | 1.03 | 1.71 | 1.97 |
Efficiency Ratios | |||||
Fixed Capital/Sales(x) | 1.02 | 1.04 | 0.87 | 0.63 | 0.70 |
Receivable days | 73.58 | 162.56 | 280.04 | 195.53 | 141.83 |
Inventory Days | 48.82 | 50.23 | 31.19 | 19.07 | 27.26 |
Payable days | 150.93 | 139.67 | 208.84 | 145.67 | 134.03 |
Valuation Parameters | |||||
PER(x) | - | - | 107.20 | - | - |
PCE(x) | -10.95 | 48.27 | 14.94 | 11.66 | 31.01 |
Price/Book(x) | 0.59 | 0.72 | 0.72 | 0.26 | 0.95 |
Yield(%) | - | - | - | - | - |
EV/Net Sales(x) | 0.65 | 1.48 | 1.07 | 0.33 | 1.40 |
EV/Core EBITDA(x) | 11.83 | 14.93 | 11.43 | 2.93 | 28.67 |
EV/EBIT(x) | -3.01 | 85.26 | 49.00 | -11.69 | -172.26 |
EV/CE(x) | 0.28 | 0.59 | 0.50 | 0.20 | 0.81 |
M Cap / Sales | 1.06 | 1.55 | 1.28 | 0.33 | 1.35 |
Growth Ratio | |||||
Net Sales Growth(%) | 11.54 | -14.40 | -27.57 | 12.09 | -11.53 |
Core EBITDA Growth(%) | -38.04 | -9.66 | -38.98 | 155.20 | -67.57 |
EBIT Growth(%) | -1,489.72 | -32.21 | 156.75 | -284.70 | -102.58 |
PAT Growth(%) | -291.09 | -419.53 | 127.65 | -191.19 | -106.40 |
EPS Growth(%) | -281.66 | -435.46 | 157.27 | -190.79 | -102.60 |
Financial Stability Ratios | |||||
Total Debt/Equity(x) | - | - | - | - | 0.04 |
Current Ratio(x) | 2.36 | 4.18 | 5.23 | 2.69 | 2.63 |
Quick Ratio(x) | 2.00 | 3.54 | 4.73 | 2.61 | 2.49 |
Interest Cover(x) | -19.97 | 1.07 | 1.78 | -1.99 | -0.98 |
Total Debt/Mcap(x) | - | 0.01 | 0.01 | 0.02 | 0.04 |
Compare Financial Ratios of peers of JHS SVENDGAARD LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JHS SVENDGAARD LABORATORIES | ₹128.5 Cr | -10.2% | -37.9% | 1.8% | Stock Analytics | |
HINDUSTAN UNILEVER | ₹532,946.0 Cr | -1.3% | -6.4% | -8.4% | Stock Analytics | |
GODREJ CONSUMER PRODUCTS | ₹128,026.0 Cr | -0.3% | -4.2% | 29.8% | Stock Analytics | |
DABUR INDIA | ₹92,704.2 Cr | 0.6% | -2.7% | -1.9% | Stock Analytics | |
COLGATEPALMOLIVE (INDIA) | ₹73,732.6 Cr | 5% | 7.8% | 81.1% | Stock Analytics | |
PROCTER & GAMBLE HYGIENE & HEALTH CARE | ₹54,816.4 Cr | NA | -1.4% | 18.8% | Stock Analytics |
JHS SVENDGAARD LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JHS SVENDGAARD LABORATORIES | -10.2% |
-37.9% |
1.8% |
SENSEX | -0.4% |
-0.9% |
25.8% |
You may also like the below Video Courses